Oncolytics Biotech releases REOLYSIN phase I clini...[Expert Rev Anticancer Ther. 2002] - PubMed Result

SearchDatabase nameforSearch term

Advanced Search

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

Click to change filter selection through MyNCBI.

1: Expert Rev Anticancer Ther. 2002 Apr;2(2):139.Links

Oncolytics Biotech releases REOLYSIN phase I clinical trial results.

[No authors listed]

PMID: 12113234 [PubMed - indexed for MEDLINE]

Related articles

ReviewDrug evaluation: Reolysin--wild-type reovirus as a cancer therapeutic.
Curr Opin Mol Ther. 2006 Jun; 8(3):249-60.

[Curr Opin Mol Ther. 2006]
Individualized quality of life, standardized quality of life, and distress in patients undergoing a phase I trial of the novel therapeutic Reolysin (reovirus).
Health Qual Life Outcomes. 2005 Jan 27; 3:7. Epub 2005 Jan 27.

[Health Qual Life Outcomes. 2005]
ReviewSatraplatin: BMS 182751, BMY 45594, JM 216.
Drugs R D. 2007; 8(2):125-32.

[Drugs R D. 2007]
ReviewTrabectedin: Ecteinascidin 743, Ecteinascidin-743, ET 743, ET-743, NSC 684766.
Drugs R D. 2006; 7(5):317-28.

[Drugs R D. 2006]
ReviewMarimastat: BB 2516, TA 2516.
Drugs R D. 2003; 4(3):198-203.

[Drugs R D. 2003]
» See reviews... | » See all...

Recent Activity

Clear Turn Off Turn On

Oncolytics Biotech releases REOLYSIN phase I clinical trial results.Oncolytics Biotech releases REOLYSIN phase I clinical trial results.

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Display Show